Haizheng Pharmaceuticals: In the first quarter of 2026, the net profit was 356 million yuan, a year-on-year increase of 83.13%.

Haizheng Pharmaceutical announced that its operating income in the first quarter of 2026 was 2.39 billion yuan, a year-on-year decrease of 9.17%. Net profit was 356 million yuan, a year-on-year increase of 83.13%. The main reason for the increase in net profit was the company's transfer of 100% equity of Zhejiang Pharmaceutical Industry Co., Ltd., resulting in an increase in non-recurring gains and losses; at the same time, the company benefited from the growth in sales of pharmaceutical preparations, as well as the continuous promotion of lean production and process optimization, achieving production cost reduction and efficiency improvement. After deducting non-recurring gains and losses, the company's net profit achieved good growth.